RBC Capital analyst Alistair Campbell raised the price target on Pharming Group (PHARM:NA) to EUR2.15 (from EUR1.60) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE